Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q5TA50
UPID:
CPTP_HUMAN
Alternative names:
Glycolipid transfer protein domain-containing protein 1
Alternative UPACC:
Q5TA50; Q4G0E6; Q7L5A4
Background:
Ceramide-1-phosphate transfer protein, also known as Glycolipid transfer protein domain-containing protein 1, plays a crucial role in the intracellular transfer of ceramide-1-phosphate (C1P) across organelle membranes to the cell membrane. It is essential for the normal structure of Golgi stacks and selectively binds phosphoceramides, favoring lipids with specific aliphatic chains. This protein is pivotal in regulating cellular levels of C1P, influencing phospholipase PLA2G4A activity, and arachidonic acid release. It also regulates autophagy, inflammasome mediated IL1B and IL18 processing, and pyroptosis.
Therapeutic significance:
Understanding the role of Ceramide-1-phosphate transfer protein could open doors to potential therapeutic strategies.